Mani, I'm not saying it will happen, only that if in reality DCVax-L turns out to be part of the SOC for many solid cancers, it could be a trillion dollar company. Sure, we may be bought out well before that, but what if we aren't. What if we partner with one or more BP's, but aren't bought out by any.
Let's be honest, we need their products too. DCVax-L by itself isn't the answer, we do need products the BP's provide, or perhaps those from other tiny biotech too.
The point is, we don't know where we'll be going over time, however, the potential could be tremendous and if we live up to that potential, there is no telling how big this could be.
Gary
Bullish
Market Data 
Markets 
